Cargando…
Outsourcing facilities and their place in the U.S. drug supply chain
The purpose of this commentary is to describe the ideal role of 503B outsourcing facilities in the U.S. drug supply chain. We also address the challenges that 503B outsourcing facilities are facing that limit their utilization and offer possible solutions. Section 503B outsourcing facilities are eme...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453203/ https://www.ncbi.nlm.nih.gov/pubmed/32863181 http://dx.doi.org/10.1016/j.japh.2020.07.021 |